Zipp F - Search Results

1

Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects.

Lill CM, Liu T, Schjeide BM, Roehr JT, Akkad DA, Damotte V, Alcina A, Ortiz MA, Arroyo R, Lopez de Lapuente A, Blaschke P, Winkelmann A, Gerdes LA, Luessi F, Fernadez O, Izquierdo G, Antigüedad A, Hoffjan S, Cournu-Rebeix I, Gromöller S, Faber H, Liebsch M, Meissner E, Chanvillard C, Touze E, Pico F, Corcia P; ANZgene Consortium,{dagger}; Dörner T, Steinhagen-Thiessen E, Baeckman L, Heekeren HR, Li SC, Lindenberger U, Chan A, Hartung HP, Aktas O, Lohse P, Kümpfel T, Kubisch C, Epplen JT, Zettl UK, Fontaine B, Vandenbroeck K, Matesanz F, Urcelay E, Bertram L, Zipp F. Lill CM, et al. Among authors: zipp f. J Med Genet. 2012 Sep;49(9):558-62. doi: 10.1136/jmedgenet-2012-101175. J Med Genet. 2012. PMID: 22972946

2

Partial synergy of bisindolylmaleimide with apoptotic stimulus in antigen-specific T cells--implications for multiple sclerosis.

Wendling U, Aktas O, Schmierer K, Zschenderlein R, Zipp F. Wendling U, et al. Among authors: zipp f. J Neuroimmunol. 2000 Feb 1;103(1):69-75. doi: 10.1016/s0165-5728(99)00214-3. J Neuroimmunol. 2000. PMID: 10674991

3

[Apoptosis in multiple sclerosis. Etiopathogenetic relevance and prospects for new therapeutic strategies].

Aktas O, Wendling U, Zschenderlein R, Zipp F. Aktas O, et al. Among authors: zipp f. Nervenarzt. 2000 Oct;71(10):767-73. doi: 10.1007/s001150050664. Nervenarzt. 2000. PMID: 11082807 Review. German.

4

Downregulation of transforming growth factor-beta1 in interferon-beta1a-treated MS patients.

Lünemann JD, Aktas O, Gniadek P, Zschenderlein R, Zipp F. Lünemann JD, et al. Among authors: zipp f. Neurology. 2001 Sep 25;57(6):1132-4. doi: 10.1212/wnl.57.6.1132. Neurology. 2001. PMID: 11571354

5

Elevated Bcl-X(L) levels correlate with T cell survival in multiple sclerosis.

Waiczies S, Weber A, Lünemann JD, Aktas O, Zschenderlein R, Zipp F. Waiczies S, et al. Among authors: zipp f. J Neuroimmunol. 2002 May;126(1-2):213-20. doi: 10.1016/s0165-5728(02)00067-x. J Neuroimmunol. 2002. PMID: 12020973

6

The role of apoptosis in neuroinflammation.

Zipp F, Aktas O, Lünemann JD. Zipp F, et al. Ernst Schering Res Found Workshop. 2002;(39):213-29. doi: 10.1007/978-3-662-05073-6_12. Ernst Schering Res Found Workshop. 2002. PMID: 12066414 Review. No abstract available.

7

Regulation of self-reactive T cells by human immunoglobulins--implications for multiple sclerosis therapy.

Aktas O, Zipp F. Aktas O, et al. Among authors: zipp f. Curr Pharm Des. 2003;9(3):245-56. doi: 10.2174/1381612033392152. Curr Pharm Des. 2003. PMID: 12570829 Review.

8

Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study.

Wuerfel J, Bellmann-Strobl J, Brunecker P, Aktas O, McFarland H, Villringer A, Zipp F. Wuerfel J, et al. Among authors: zipp f. Brain. 2004 Jan;127(Pt 1):111-9. doi: 10.1093/brain/awh007. Epub 2003 Oct 21. Brain. 2004. PMID: 14570816

9

Identification and functional characterization of a highly polymorphic region in the human TRAIL promoter in multiple sclerosis.

Weber A, Wandinger KP, Mueller W, Aktas O, Wengert O, Grundström E, Ehrlich S, Windemuth C, Kuhlmann T, Wienker T, Brück W, Zipp F. Weber A, et al. Among authors: zipp f. J Neuroimmunol. 2004 Apr;149(1-2):195-201. doi: 10.1016/j.jneuroim.2003.12.014. J Neuroimmunol. 2004. PMID: 15020080

10

Death ligands and autoimmune demyelination.

Aktas O, Prozorovski T, Zipp F. Aktas O, et al. Among authors: zipp f. Neuroscientist. 2006 Aug;12(4):305-16. doi: 10.1177/1073858405285208. Neuroscientist. 2006. PMID: 16840707 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

403 results

Search Page